News and Announcements
Strategic Acquisition of ADVANGEN INC., Japan boosts cashflow
- Published May 16, 2013 4:54PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
ASX ANNOUNCEMENT , May 16, 2013
- Immediate access to sales from established Japanese hair growth market
- Whole-of-chain acquisition; reduced cost of goods and no royalties on évolis
- Global rights including China with recently granted import permits
- Boosts Cellmid’s products development expertise to facilitate the midkine hair growth program
Sydney, Wednesday, 8 May 2013: Cellmid Limited (ASX:CDY) is pleased to advise that it will acquire Advangen Inc., Japan (Advangen), the company that owns the FGF-5 inhibitor hair growth technology. This is a high strategic acquisition that will significantly increase Cellmid’s revnues in the short to medium term.
To read the full announcement, please download the document below.